Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 8, 2013, Pages 1680-1691

  Fusar Poli, P ^a   Smieskova, R ^b   Kempton, M J ^a   Ho, B C ^c   Andreasen, N C ^c   Borgwardt, S ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Antipsychotic; Dopamine; MRI; Neuroimaging; Psychosis; Schizophrenia; Structural

Indexed keywords

NEUROLEPTIC AGENT;

BRAIN SIZE; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; DISEASE DURATION; DISEASE SEVERITY; GRAY MATTER; HUMAN; LATERAL BRAIN VENTRICLE; LONGITUDINAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; WHITE MATTER;

ANTIPSYCHOTIC; DOPAMINE; MRI; NEUROIMAGING; PSYCHOSIS; SCHIZOPHRENIA; STRUCTURAL;

ANTIPSYCHOTIC AGENTS; BRAIN; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA;

EID: 84880417244     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.06.001     Document Type: Review

References (96)

1. Agid O., Kapur S., Arenovich T., Zipursky R. Delayed onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch. Gen. Psychiatry 2003, 60:1228-1235.
2. Agid O., Kapur S., Arenovich T., Zipursky R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch. Gen. Psychiatry 2003, 60:1228-1235.
3. Andreasen N.C., Nopoulos P., Magnotta V., Pierson R., Ziebell S., Ho B.C. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol. Psychiatry 2011, 70:672-679.
4. Andreasen N.C., Wilcox M.A., Ho B.C., Epping E., Ziebell S., Zeien E., Weiss B., Wassink T. Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. Mol. Psychiatry 2012, 17:1093-1102.
5. Arango C., Rapado-Castro M., Reig S., Castro-Fornieles J., González-Pinto A., Otero S., Baeza I., Moreno C., Graell M., Janssen J., Parellada M., Moreno D., Bargalló N., Desco M. Progressive brain changes in children and adolescents with first-episode psychosis. Arch. Gen. Psychiatry 2012, 69:16-26.
6. Boonstra G., van Haren N.E., Schnack H.G., Cahn W., Burger H., Boersma M., de Kroon B., Grobbee D.E., Hulshoff Pol.H.E., Kahn R.S. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. J. Clin. Psychopharmacol. 2011, 31:146-153.
7. Borenstein M.H.L., Higgins J., Rothstein H. Comprehensive Meta-Analysis Version 2 2005, Biostat, Englewood, NJ, USA.
8. Borgwardt S., Koutsouleris N., Aston J., Studerus E., Smieskova R., Riecher-Rossler A., Meisenzahl E.M. Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition. Schizophr Bull. 2012.
9. Borgwardt S.J., McGuire P.K., Aston J., Gschwandtner U., Pfluger M.O., Stieglitz R.D.s, Radue E.W., Riecher-Rossler A. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr. Res. 2008, 106:108-114.
10. Cahn W., van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Caspers E., Laponder D.A., Kahn RS Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br. J. Psychiatry 2006, 189:381-382.
11. Chakos M.H., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts B., Wu H., Kinon B., Ashtari M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry 1994, 151:1430-1436.
12. Chan R.C., Di X., McAlonan G.M., Gong Q. Brain anatomical abnormalities in high risk individuals, first episode and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr. Bull. 2009, (24 July Epub).
13. Collin G., Derks E.M., van Haren N.E., Schnack H.G., Hulshoff Pol H.E., Kahn R.S., Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophr. Res. 2012, 138:171-176.
14. Cook R., Weisberg S. Residuals and Influence in Regression 1982, Chapman & Hall, New York.
15. Cooper H., Hedges L., Valentine J. Handbook of Research Synthesis and Meta-Analysis 2009, Russell Sage Foundation, New York.
16. Courchesne E., Chisum H.J., Townsend J., Cowles A., Covington J., Egaas B., Harwood M., Hinds S., Press G.A. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000, 216:672-682.
17. Crespo-Facorro B., Roiz-Santiáñez R., Pérez-Iglesias R., Pelayo-Terán J.M., Rodríguez-Sánchez J.M., Tordesillas-Gutiérrez D., Ramírez M., Martínez O., Gutiérrez A., de Lucas E.M., Vázquez-Barquero J.L. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1936-1943.
18. de Bresser J., Portegies M.P., Leemans A., Biessels G.J., Kappelle L.J., Viergever M.A. A comparison of MR based segmentation methods for measuring brain atrophy progression. Neuroimage 2011, 54:760-768.
19. DeLisi L.E., Sakuma M., Maurizio A.M., Relja M., Hoff A.L. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res. 2004, 130:57-70.
20. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
22. Frazier J.A., Giedd J.N., Kaysen D., Albus K., Hamburger S., Alaghband-Rad J., Lenane M.C., McKenna K., Breier A., Rapoport J.L. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am. J. Psychiatry 1996, 153:564-566.
23. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rössler A., Schultze-Lutter F., Keshavan M., Wood S., Ruhrmann S., Seidman L., Valmaggia L., Cannon T., Velthorst E., De Haan L., Cornblatt B., Birchwood M., McGlashan T., Carpenter W., McGorry P., Klosterkötter J., McGuire P., Yung A. The psychosis high risk state: a comprehensive state of the art review. JAMA Psychiatry 2012, 70(1):107-120. 10.1001/jamapsychiatry.2013.269.
24. Fusar-Poli P., Borgwardt S., Crescini A., D'Este G., Kempton M., Lawrie S., Guire P.M., Sacchetti E. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:1175-1185.
25. Fusar-Poli P., Broome M.R., Matthiasson P., Williams S.C., Brammer M., McGuire P.K. Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. Eur. Neuropsychopharmacol. 2007, 17:492-500.
26. Fusar-Poli P., Deste G., Smieskova R., Barlati G., Yung A.R., Howes O., Stieglitz R., McGuire P., Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry 2012, 69(6):562-571. 10.1001/archgenpsychiatry.2011.1592.
27. Fusar-Poli P., Radua J., McGuire P., Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr. Bull. 2012, 38(6):1297-1307. Epub 2011 Nov 10. 10.1093/schbul/sbr134.
28. Garver D.L., Holcomb J.A., Christensen J.D. Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biol. Psychiatry 2005, 58:62-66.
29. Good C.D., Johnsrude I., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001, 14:685-700.
30. Gur R.E., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry 1998, 55:145-152.
31. Haijma S.V., Van Haren N., Cahn W., Koolschijn P.C., Hulshoff Pol H.E., Kahn R.S. Brain volumes in schizophrenia: a meta-analysis in over 18000 subjects. Schizophr. Bull. 2012.
32. Handley R., Zelaya F.O., Reinders A.A., Marques T.R., Mehta M.A., O'Gorman R., Alsop D.C., Taylor H., Johnston A., Williams S., McGuire P., Pariante C.M., Kapur S., Dazzan P. Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain. Hum. Brain Mapp. 2012.
33. Heitmiller D.R., Nopoulos P.C., Andreasen N.C. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent. Schizophr. Res. 2004, 66:137-142.
34. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry 2003, 60:585-594.
35. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 2011, 68:128-137.
36. Horga G., Bernacer J., Dusi N., Entis J., Chu K., Hazlett E.A., Haznedar M.M., Kemether E., Byne W., Buchsbaum M.S. Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:467-476.
37. Hulshoff Pol H., Kahn R. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008, 34:354-366. (Epub February 2008).
38. Ioannidis J.P. Excess significance bias in the literature on brain volume abnormalities. Arch. Gen. Psychiatry 2011, 68:773-780.
39. James A.C., James S., Smith D.M., Javaloyes A. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. Am. J. Psychiatry 2004, 161:1023-1029.
40. Johnstone E.C., Crow T.J., Frith C.D., Husband J., Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976, 2:924-926.
41. Kempton M., Stahl D., Williams S.C., DeLisi L. Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophr. Res. 2010, 120:54-62.
42. Kendall T. The rise and fall of the atypical antipsychotics. Br. J. Psychiatry 2011, 199:266-268.
43. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N.R., Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet 1994, 344:1434.
44. Konopaske G.T., Dorph-Petersen K.A., Sweet R.A., Pierri J.N., Zhang W., Sampson A.R., Lewis D.A. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry 2008, 63:759-765.
45. Koutsouleris N., Gaser C., Patschurek-Kliche K., Scheuerecker J., Bottlender R., Decker P., Schmitt G., Reiser M., Moller H.J., Meisenzahl E.M. Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis. Hum. Brain Mapp. 2012, 33:2104-2124.
46. Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., Goghari V.M., Lapointe J.S., Honer W.G. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am. J. Psychiatry 2004, 161:1829-1836.
47. Leucht S., Kane J.M., Etschel E., Kissling W., Hamann J., Engel R.R. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology 2006, 31:2318-2325.
48. Leucht S., Kissling W., Davis J.M. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?. Psychol. Med. 2009, 39:1591-1602.
49. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 2005, 62:361-370.
50. Lipsey M., Wilson D. Practical Meta-analysis 2000, Thousand Oaks, CA, Sage Publications.
51. Long X., Liao W., Jiang C., Liang D., Qiu B., Zhang L. Healthy aging: an automatic analysis of global and regional morphological alterations of human brain. Acad. Radiol. 2012, 19:785-793.
52. Lui S., Li T., Deng W., Jiang L., Wu Q., Tang H., Yue Q., Huang X., Chan R.C., Collier D.A., Meda S.A., Pearlson G., Mechelli A., Sweeney J.A., Gong Q. Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by resting state functional magnetic resonance imaging. Arch. Gen. Psychiatry 2010, 67:783-792.
53. Lyne J.P., Kinsella A., O'Donoghue B. Can we combine symptom scales for collaborative research projects?. J. Psychiatr. Res. 2012, 46:233-238.
54. Martin-Santos R., Fagundo A.B., Crippa J.A., Atakan Z., Bhattacharyya S., Allen P., Fusar-Poli P., Borgwardt S., Seal M., Busatto G.F., McGuire P. Neuroimaging in cannabis use: a systematic review of the literature. Psychol. Med. 2010, 40:383-398.
55. Massana G., Salgado-Pineda P., Junqué C., Pérez M., Baeza I., Pons A., Massana J., Navarro V., Blanch J., Morer A., Mercader J.M., Bernardo M. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J. Clin. Psychopharmacol. 2005, 25:111-117.
56. McClure R.K., Carew K., Greeter S., Maushauer E., Steen G., Weinberger D.R. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment. Schizophr. Res. 2008, 98:29-39.
57. Mechelli A., Riecher-Rossler A., Meisenzahl E.M., Tognin S., Wood S.J., Borgwardt S.J., Koutsouleris N., Yung A.R., Stone J.M., Phillips L.J., McGorry P.D., Valli I., Velakoulis D., Woolley J., Pantelis C., McGuire P. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch. Gen. Psychiatry 2011, 68:489-495.
58. Miyamoto S., Duncan G.E., Marx C.E., Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 2005, 10:79-104.
59. Modinos G., Costafreda S.G., van Tol M.J., McGuire P.K., Aleman A., Allen P. Neuroanatomy of Auditory Verbal Hallucinations in Schizophrenia: A Quantitative Meta-Analysis of Voxel-Based Morphometry Studies 2012, Cortex.
60. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
61. Molina V., Reig S., Sanz J., Palomo T., Benito C., Sánchez J., Sarramea F., Pascau J., Desco M. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr. Res. 2005, 80:61-71.
62. Moncrieff J., Leo J. A systematic review of the effects of antipsychotic drugs on brain volume. Psychol. Med. 2010, 40:1409-1422.
63. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 2007, 62:773-783.
64. Navari S., Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol. Med. 2009, 39:1763-1777.
65. Olabi B., Ellison-Wright I., McIntosh A.M., Wood S.J., Bullmore E., Lawrie S.M. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol. Psychiatry 2011, 70:88-96.
66. Orwin R. A fail-safe N for effect size in meta-analysis. J. Edu. Stat. 1983, 8:157-159.
67. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
68. Paulson J.F., Bazemore S.D. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 2010, 303:1961-1969.
69. Puri B.K., Hutton S.B., Saeed N., Oatridge A., Hajnal J.V., Duncan L., Chapman M.J., Barnes T.R., Bydder G.M., Joyce E.M. A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Res. 2001, 106:141-150.
70. Radua J., Borgwardt S., Crescini A., Mataix-Cols D., Meyer-Lindenberg A., McGuire P., Fusar-Poli P. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci. Biobehav. Rev. 2012, 36:2325-2333.
71. Radua J., Mataix-Cols D. Meta-analytic methods for neuroimaging data explained. Biol. Mood Anxiety Disord. 2012, 2:6.
72. Rais M., Cahn W., Van Haren N., Schnack H., Caspers E., Hulshoff Pol H., Kahn R. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry 2008, 165:490-496.
73. Reig S., Moreno C., Moreno D., Burdalo M., Janssen J., Parellada M., Zabala A., Desco M., Arango C. Progression of brain volume changes in adolescent-onset psychosis. Schizophr. Bull. 2009, 35:233-243.
74. Saijo T., Abe T., Someya Y., Sassa T., Sudo Y., Suhara T., Shuno T., Asai K., Okubo Y. Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin. Neurosci. 2001, 55:41-47.
75. Sayo A., Jennings R.G., Van Horn J.D. Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis. Neuroimage 2012, 59:154-167.
76. Schaufelberger M.S., Lappin J.M., Duran F.L., Rosa P.G., Uchida R.R., Santos L.C., Murray R.M., McGuire P.K., Scazufca M., Menezes P.R., Busatto G.F. Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol. Med. 2011, 41:1677-1689.
77. Scheepers F.E., de Wied C.C., Hulshoff Pol H.E., van de Flier W., van der Linden J.A., Kahn R.S. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 2001, 24:47-54.
78. Shepherd A.M., Laurens K.R., Matheson S.L., Carr V.J., Green M.J. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci. Biobehav. Rev. 2012, 36:1342-1356.
79. Sherwood M., Thornton A.E., Honer W.G. A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics. Int. J. Neuropsychopharmacol. 2006, 9:357-366.
80. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rossler A., Borgwardt S.J. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? - A systematic review. Curr. Pharm. Des. 2009, 15:2535-2549.
81. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rossler A., Borgwardt S.J. Neuroimaging predictors of transition to psychosis - a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2010, 34:1207-1222.
82. Sporn A.L., Greenstein D.K., Gogtay N., Jeffries N.O., Lenane M., Gochman P., Clasen L.S., Blumenthal J., Giedd J.N., Rapoport J.L. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am. J. Psychiatry 2003, 160:2181-2189.
83. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br. J. Psychiatry 2008, 192:248-257.
84. Takahashi T., Wood S.J., Soulsby B., McGorry P.D., Tanino R., Suzuki M., Velakoulis D., Pantelis C. Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr. Res. 2009, 108:49-56.
85. Tauscher-Wisniewski S., Tauscher J., Christensen B.K., Mikulis D.J., Zipursky R.B. Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis. J. Psychiatr. Res. 2005, 39:365-370.
86. Tauscher-Wisniewski S., Tauscher J., Logan J., Christensen B.K., Mikulis D.J., Zipursky R.B. Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study. Schizophr. Res. 2002, 58:185-188.
87. Taylor S., Christensen J.D., Holcomb J.M., Garver D.L. Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation. Psychiatry Res. 2005, 140:85-89.
88. Tost H., Braus D.F., Hakimi S., Ruf M., Vollmert C., Hohn F., Meyer-Lindenberg A. Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat. Neurosci. 2010, 13:920-922.
89. van Haren N.E., Cahn W., Hulshoff Pol H.E., Schnack H.G., Caspers E., Lemstra A., Sitskoorn M.M., Wiersma D., van den Bosch R.J., Dingemans P.M., Schene A.H., Kahn R.S. Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr. Res. 2003, 64:41-52.
90. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Brans R., Carati I., Rais M., Kahn R.S. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry 2008, 63:106-113.
91. Venkatasubramanian G. Neuroanatomical correlates of psychopathology in antipsychotic-naive schizophrenia. Indian J. Psychiatry 2010, 52:28-36.
92. Vernon A.C., Natesan S., Crum W.R., Cooper J.D., Modo M., Williams S.C., Kapur S. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol. Psychiatry 2012, 71:855-863.
93. Vita A., De Peri L. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int. Rev. Psychiatry 2007, 19:429-436.
94. Weinberger D.R., McClure R.K. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Arch. General Psychiatry 2002, 59:553-558.
95. Whitworth A.B., Kemmler G., Honeder M., Kremser C., Felber S., Hausmann A., Walch T., Wanko C., Weiss E.M., Stuppaeck C.H., Fleischhacker W.W. Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Res. 2005, 140:225-237.
96. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 2000, 157:16-25.